We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DDMAC: Consumer Herceptin Video Doesn’t Balance Risk Information
DDMAC: Consumer Herceptin Video Doesn’t Balance Risk Information
April 30, 2010
The FDA has issued an untitled letter to Genentech for a patient video that overstates the efficacy of its breast cancer drug Herceptin and minimizes its
risks.